Adiposs is a Swiss biotech start-up company developing medical imaging products and technologies for early detection of cachexia.

Cachexia

Cachexia is a fatal body wasting syndrome characterized by involuntary weight loss, muscle atrophy, fatigue, weakness and loss of appetite. 


9 million patients diagnosed with cancer every year are affected by cachexia. It dramatically reduces their quality of life, response and tolerance to cancer therapies and survival. 


1 in 4 cancer patients dies as a consequence of cachexia and not cancer itself, yet doctors do not know when cachexia begins.

ImageBAT

ImageBAT is a new CT contrast agent which enables early detection of cachexia before patients lose body weight.  Detection of cachexia will be fast, pain-free and available in every hospital worldwide. ImageBAT will give millions of cancer patients an improved quality of life and a better chance to survive cancer.

About ImageBAT

News

Adiposs won 150'000 CHF from Venture Kick

06.05.2020

Adiposs is very proud to have won 150'000 CHF in the third stage of Venture Kick. This convertible loan will help Adiposs moving forward towards clinical development.

Adiposs is going to Boston!

22.04.2020

Adiposs has been selected for this year’s Venture Leaders Life Sciences program. With nine other startups, Adiposs will take part to a one-week roadshow in Boston organized by Venturelab

Adiposs was part of the AIT India program

07.02.2020

The Swiss-Indian Academia-Industry Training Camp took place last week in Switzerland after being held in India last September. Adiposs is proud to be one of the four winners of the pitching competition. 

Prizes

2020: Adiposs wins support from Venture Kick stage 3

2020: Adiposs wins support from Venture Kick stage 3

2020: Adiposs wins support from Venture Kick stage 3

image1

2019: Adiposs wins support of Venture Kick

2020: Adiposs wins support from Venture Kick stage 3

2020: Adiposs wins support from Venture Kick stage 3

image2

2018: 'Best Project' at BioInnovation Day in Geneva

2017: 'Trophy of Innovation' by HUG in Geneva

2017: 'Trophy of Innovation' by HUG in Geneva

image3

2017: 'Trophy of Innovation' by HUG in Geneva

2017: 'Trophy of Innovation' by HUG in Geneva

2017: 'Trophy of Innovation' by HUG in Geneva

image4

Team

image5

Andrej BABIC PhD

Nathalie STRANSKY PhD

Andrej BABIC PhD

      Andrej is the Chief Executive Officer and co-founder of Adiposs. He is the co-inventor of ImageBAT. Andrej has worked in the field of diagnostic imaging for over 10 years leading multidisciplinary teams and projects in academic and start-up environment. He is a  co-author of 30+ scientific papers and owner of several patents in the fields of diagnostics, photodynamic therapy and nanotechnology. 

image6

Justyna PLEWKA

Nathalie STRANSKY PhD

Andrej BABIC PhD

    Justyna is the Chief Operating Officer and co-founder of Adiposs. She has over 10 years of extensive business, finance and competitive intelligence experience. She has spent a big part of her professional life working at KPMG where she provided audit, advisory and due diligence services to a wide range of public and private companies in multiple jurisdictions.

image7

Nathalie STRANSKY PhD

Nathalie STRANSKY PhD

Nathalie STRANSKY PhD

    Nathalie is the Chief Scientific Officer.  

She has more than 8 years of experience in developing advanced pharmaceutical formulations and medical imaging agents. She is an expert in nano-sized pharmaceutical systems and also has experience in designing clinical trials.

Our Partners

image8
image9
image10
image11
image12
image13
image14
image15
image16
image17

Contact Us

Adiposs

c/o Foundation Eclosion

Chemin des Aulx 14

1228 Plan-les-Ouates 

Switzerland


info@adiposs.com


+41 76 61 61 624